Purchase BIT to provide protection from biological attack?! Now I've heard it all lol!
Speccy biotechs only need to limp along each year to receive approval of their remuneration report, raising capital occasionally to make glacial progress on drug candidate development.
95%+ of them fail... I can't see any reason why BIT won't be represented in that statistic (eventually).
BIT Price at posting:
7.2¢ Sentiment: None Disclosure: Not Held
